58 employees
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
2021
$68M
from 3 investors over 3 rounds
Exai Bio raised $68M on December 9, 2021
Investors: Two Sigma Ventures, Casdin Capital, LLC and Section 32